Principles of Macroeconomics (12th Edition)
12th Edition
ISBN: 9780134078809
Author: Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher: PEARSON
expand_more
expand_more
format_list_bulleted
Question
Chapter 21, Problem 2.2P
Sub part (a):
To determine
Calculate the death rate in group A.
Sub part (b):
To determine
Calculate the death rate in group B.
Sub part (c):
To determine
Identify the suggestions for the reduction in death rate.
Sub part (d):
To determine
Identify the effectiveness of insecticide treatment using intention-to treat method.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solutionStudents have asked these similar questions
The government would like to introduce a subsidy to help citizens who need their car for
work and cannot afford to buy a ULEZ-compliant car. It also wants to ensure that only
citizens who need to drive their car regularly use the subsidy. Instead of the two groups of
citizens discussed above, we focus on one particular citizen who does not drive very often,
only once a year. As a result, this citizen does not emit excessive pollution even with a car
that is not ULEZ-compliant. The government would therefore prefer citizens like her not to
buy a new car to avoid having to pay the subsidy unnecessarily. Once a year, the citizen
derives a benefit of driving through the ULEZ area of B = 20. She can choose to either buy a
new ULEZ-compliant car at a cost of C = 10, 000, denoted x = new, or stick with her old car
at no cost, denoted x = old.If she sticks with her old car, she has to pay a ULEZ fee of t =
12.50 on the day that she drives. Her net benefit of driving on that day is therefore…
The government would like to introduce a subsidy to help citizens who need their car for work and cannot afford to buy a ULEZ-compliant car. It also wants to ensure that only citizens who need to drive their car regularly use the subsidy. Instead of the two groups of citizens discussed above, we focus on one particular citizen who does not drive very often, only once a year. As a result, this citizen does not emit excessive pollution even with a car that is not ULEZ-compliant. The government would therefore prefer citizens like her not to buy a new car to avoid having to pay the subsidy unnecessarily.
Once a year, the citizen derives a benefit of driving through the ULEZ area of B = 20. She can choose to either buy a new ULEZ-compliant car at a cost of C = 10, 000, denoted x = new, or stick with her old car at no cost, denoted x = old.
5
If she sticks with her old car, she has to pay a ULEZ fee of τ = 12.50 on the day that she drives. Her net benefit of driving on that day is…
While randomized control trials are gold-standard, we don't use them in economics often to explore causal relationships. Why? Provide three reasons.
Chapter 21 Solutions
Principles of Macroeconomics (12th Edition)
Knowledge Booster
Similar questions
- The Customs Inspection agency at international airports has developed a traveler profiling system (TPS) to detect passengers who are trying to bring more liquor into the country than is allowed by present regulations. Long-term studies indicate that 20% of the passengers are carrying more liquor than is allowed. Tests on the new TPS scheme has shown that of those carrying illegal amounts of liquor, 80% will be identified and subject to complete luggage search. In addition 20% of those not carrying illegal amounts of liquor will also be identified by TPS and subject to a complete luggage search.If a passenger is identified by TPS, what is the probability that the passenger is carrying an illegal amount of liquor? Comment on the value of this system.arrow_forwardOne of the pitfalls of Randomized Control Trials is that: Hard to ensure that people who are randomly assigned to treatment group are actually treated. Hard to come up with reasonable alternatives that are uniquely different from the control groups Control Group Contamination. All of the above. None of the above.arrow_forward(This question assumes that daily life has returned to the way it used-to-be before the Covid-19 pandemic.) Suppose that technological advancements in high-speed rail transport has led some people to substitute rail travel for driving to their holiday destinations. A study by Professor Q of Nomash University found that the reduction in car travel led to fewer road traffic accidents and deaths per year, since rail travel is safer (per passenger kilometre) than car travel. a) Using the logic suggested by Professor Q, illustrate and explain with demand and supply curves how a rise in wages paid to all rail-transport employees would affect the number of road accidents and deaths per year. (Hint clearly identify which market you will use to analyse the question.) b) How would your conclusion to part (a) change if, in addition to the rise in wages mentioned above, there is a significant decrease in rental rates for minibuses or passenger vans? Illustrate and explain your reasoning.arrow_forward
- Suppose a US medical board is using marginal analysis to determine the optimal screening frequency for a specific disease. Below is the approximate number of early cases that screening at various frequencies will detect. The frequency of screening is how often the entire population (of 5,000 people) will be screened over a 10-year period. For example, a Frequency of 5 means the entire population will be will be screened 5 times over a 10-year period. Suppose further that each early detection case is considered to have a benefit of $50,000 and the cost of screening the population is $9,000,000. Frequency of screening the population (number of times over 10 year period) 10 1 12 3 14 Total Number of Early Detection Cases 10 400 700 900 1000 1000 I 5 Using the marginal benefit/marginal cost rule, what is the optimal frequency for screening (over this ten-year period)? 2 times 5 times 3 times 4 timesarrow_forwardHerd immunity is not a new term. We know there is risk, controversy, and misinformation associated with vaccines. For this discussion, we will focus on Herd immunity and economics associated with disease management. Globally, many health experts are working to understand disease origin, progression, and the overall financial impacts of disease management. When it comes to pandemics such as COVID-19, what is the economic difference between treatments with preventative measures (vaccines) versus treating patients post infection for complications as needed? What makes the most economic sense as we move toward the goal of herd immunity?arrow_forwardEconomic Epidemiology Suppose that some members of a population are infected with a sexually transmitted virus that causes disease X, and some are infected with another sexually transmitted virus that causes disease Y. Some members of the population may be infected with both viruses. While diseases X and Y are similar in that they are both sexually transmitted diseases, the disease X is much more harmful to its carriers than the disease Y is to its carriers. Condom use is highly effective in preventing the transmission of either disease. Suppose scientists discover a cure for the sexually transmitted disease X. This cure (a vaccination) will eliminate the virus causing the disease X from its carrier before its carrier can suffer any harm from the virus. Everybody is immediately given this vaccination against the disease X. a What do you expect to happen to the prevalence of the virus causing the disease X in the population? Draw a graph with time on the horizontal axis and prevalence…arrow_forward
- The insured population requiring care from the health services falls into one of two groups (pathologies to treat): type A and type B patients. Let's assume that there is only one patient per group. So, there are patients of one type (A) with a disease that reduces their health status in 5 QALYS, and there are patients of another type (B) with an illness that reduces their health status in 3 QALYS. Several drugs are available to the population. The more expensive they are, the greater their efficacy and the greater the number of QALYS gained. The price of a drug is related to its effectiveness and the price of the drug rises by one monetary unit for each additional QALY it provides. Therefore, to be able to restore their health, type A patients need a drug priced at 5 monetary units, and type B patients need a drug priced at 3 monetary units. Both patients (A and B) have the same income, 10 monetary units. What sacrifice, in welfare units per QALY, must a type B patient endure to be…arrow_forwardAn article in JAMA by Mandelblatt et al (2002) compared the societal costs and benefits of human papillomavirus (HPV) testing, Pap testing, and their combination to screen for cervical cancer. The paper studied 18 different population screening strategies – Pap testing alone, HPV testing alone, and Pap plus HPV testing – every 2 or 3 years for women beginning at age 20 and continuing to 65 years, 75 years, and death. The following table summarizes some of the results (low cost to high cost). Costs include screening and treatment costs, discounted over the individual’s expected lifetime. Strategy Cost ($) QALYs Saved Incremental Cost Incremental QALY ICER* 0. No screening 5,000 26.87 1. Pap every 3 years to age 75 6,825 27.02 2. HPV every 3 years to age 75 6,950 27.02 3. Pap every 2 years to age 75 7,275 27.04 4. Pap + HPV every 3 years to age 75 7,400 27.04 5. HPV every 2 years to age 75 7,450…arrow_forwardSocially conscious investors screen out stocks of alcohol and tobacco makers, firms with poor environmental records, and companies with poor labor practices. Some examples of "good," socially conscious companies are Johnson and Johnson, Dell Computers, Bank of America, and Home Depot. The question is, are such stocks overpriced? One measure of value is the P/E, or price-to-earnings ratio. High P/E ratios may indicate a stock is overpriced. For the S&P Stock Index of all major stocks, the mean P/E ratio is ? = 19.4. A random sample of 36 "socially conscious" stocks gave a P/E ratio sample mean of x = 17.8, with sample standard deviation s = 5.2. Does this indicate that the mean P/E ratio of all socially conscious stocks is different (either way) from the mean P/E ratio of the S&P Stock Index? Use ? = 0.05. What is the value of the sample test statistic? (Round your answer to three decimal places.)=__arrow_forward
- The residential division of Prism's high-speed Internet service uses one advertising agency, while its commercial division uses another. Two analysts, Andy and Brad, are asked to test the effectiveness of the two agencies. Andy proposes an A/B test that compares the click-through rates per ad of the two agendles. Brad proposes a difference-In-difference test in which the budgets for both agencies are increased by 50%, and the percentage changes in the click-through rates are compared. True or False: Andy's proposal is more likely than Brad's to suffer from blas due to issues with "representativeness." True False 2017-arrow_forwardIf the expected age of death for a male aged 20 is 75, then a 20-year-old man who dies it's considered to have lost how many years of life?arrow_forwardSuppose a US medical board is using marginal analysis to determine the optimal screening frequency for a specific disease. Below is the approximate number of early cases detected as you expand testing to a broarder population. Suppose further that each early detection case is considered to have a benefit of $50,000 and the cost of screening one person is $20,000. Number of people Total Number of screened in a Early Detection given a year Cases 1,000 500 2,000 1000 3,000 1400 4,000 1700 5,000 1900 The marginal benefit to screening 2 thousand people is, and 3 thousand people is 500 early detection cases ($25,000,000); 400 cases ($20,000,000) 1000 early detection cases ($50,000,000); 1400 ($70,000,000) early cases O 1400 ($70,000,000) early cases; 1000 early detection cases ($50,000,000) 400 cases ($20,000,000); 500 early detection cases ($25,000,000) Parrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- Principles of Economics (12th Edition)EconomicsISBN:9780134078779Author:Karl E. Case, Ray C. Fair, Sharon E. OsterPublisher:PEARSONEngineering Economy (17th Edition)EconomicsISBN:9780134870069Author:William G. Sullivan, Elin M. Wicks, C. Patrick KoellingPublisher:PEARSON
- Principles of Economics (MindTap Course List)EconomicsISBN:9781305585126Author:N. Gregory MankiwPublisher:Cengage LearningManagerial Economics: A Problem Solving ApproachEconomicsISBN:9781337106665Author:Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike ShorPublisher:Cengage LearningManagerial Economics & Business Strategy (Mcgraw-...EconomicsISBN:9781259290619Author:Michael Baye, Jeff PrincePublisher:McGraw-Hill Education
Principles of Economics (12th Edition)
Economics
ISBN:9780134078779
Author:Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:PEARSON
Engineering Economy (17th Edition)
Economics
ISBN:9780134870069
Author:William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:PEARSON
Principles of Economics (MindTap Course List)
Economics
ISBN:9781305585126
Author:N. Gregory Mankiw
Publisher:Cengage Learning
Managerial Economics: A Problem Solving Approach
Economics
ISBN:9781337106665
Author:Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike Shor
Publisher:Cengage Learning
Managerial Economics & Business Strategy (Mcgraw-...
Economics
ISBN:9781259290619
Author:Michael Baye, Jeff Prince
Publisher:McGraw-Hill Education